Efficacy in the majority of participants, safety data and consistent manufacturing are the three requirements that are needed before we are able to file for Emergency Use Authorization.
Mostrar este hilo
UPDATE: We are proud to announce, along with @BioNTech_Group, that our mRNA-based #vaccine candidate has, at an interim analysis, demonstrated initial evidence of efficacy against #COVID19 in participants without prior evidence of SARS-CoV-2 infection.
-
-
-
This is a first but critical step as we continue our work to try to deliver a safe and effective
#COVID19 vaccine.Mostrar este hilo
Final de la conversación
Conversación nueva -
-
-
How is it transported and stored?
-
liquid nitrogen (-170°C), but also has shipping equipment at other temperatures. (Generally speaking, the cutoff between “frozen” and “cryogenic” is at -150°C) https://www.pharmaceuticalcommerce.com/clinical-operations/covid-19-vaccines-chilled-frozen-or-cryogenic/ …
- Mostrar respuestas
Conversación nueva -
-
-
I love the timing of this. Well played
@pfizer
-
Merely polite statement. It has been achieved by the work of
@realDonaldTrump - Mostrar respuestas
Conversación nueva -
-
-
Hope springs eternal, excellent work.
Gracias. Twitter usará esto para mejorar tu cronología. DeshacerDeshacer
-
-
-
Gracias. Twitter usará esto para mejorar tu cronología. DeshacerDeshacer
-
-
-
Thank you for such a lovely video of someone doing an ELISA. I hope you don't mind me using it when I'm struggling to explain what I have done for my 27 year career.
-
At least you can have a clear few seconds to show without tension and frustration how hard you work getting it all in there. Btw thank you for your dedication on all you have done in the field all these years that may go unappreciated.
Final de la conversación
Conversación nueva -
Parece que el contenido está tardando un poco en cargarse.
Puede que Twitter esté saturado o experimentando un problema momentáneo. Inténtalo de nuevo o visita el Estado de Twitter para más información.